← FDA Drug Approvals (Drugs@FDA)

ZEVALIN

BLA · Biologics License Application · Sponsor: SPECTRUM PHARMS · Approved 2002-02-19

Drug application

FDA Application #
BLA125019
Application type
Biologics License Application
Brand name
ZEVALIN
Generic name
IBRITUMOMAB TIUXETAN
Active ingredients
IBRITUMOMAB TIUXETAN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SPECTRUM PHARMS
Manufacturer
Acrotech Biopharma Inc
First approval
2002-02-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown